Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

NETWORK 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5

Conditions

Uterine Cervical Neoplasms 5Medulloblastoma 5Neuroblastoma 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Carcinoma 3Vulvar Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Teratoma 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sertoli-Leydig Cell Tumor 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nausea 1Lymphoid Interstitial Pneumonia 1Hodgkin Disease 1Hepatoblastoma 1HIV Infections 1Granulosa cell tumor of the ovary 1

Interventions

Vincristine 9Cyclophosphamide 8Cisplatin 7Radiotherapy 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Radiation 4Lomustine 4Filgrastim 4Etoposide 4Carboplatin 4Magnetic Resonance Spectroscopy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3sodium thiosulfate 2merphos 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Methotrexate 2sonidegib 1silmitasertib 1sargramostim 1ribociclib 1palbociclib 1omburtamab I-131 1lonafarnib 1laromustine 1emvododstat 1azurin (50-77) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Medulloblastoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02724579 2026-05-20

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

Children's Oncology Group

Phase 2 Active not recruiting
45 enrolled
CNS

Medulloblastoma

NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

NCT00336024 2026-01-23

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

Children's Oncology Group

Phase 3 Completed
91 enrolled 24 charts
CNS

Medulloblastoma

NCT00392327 2025-06-13

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Children's Oncology Group

Phase 3 Active not recruiting
379 enrolled 29 charts
CNS

Medulloblastoma

NCT00085735 2025-01-14

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Children's Oncology Group

Phase 3 Completed
549 enrolled 32 charts
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡